New Ray Medicine International Holding (HKSE:06108) Margin of Safety % (DCF FCF Based): N/A (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06108 New Ray Medicine International Holding Ltd HKSE:06108
52 GF Score
Price HK$0.23
GF Value HK$1.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is New Ray Medicine International Holding Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

New Ray Medicine International Holding's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

New Ray Medicine International Holding Margin of Safety % (DCF FCF Based) Competitor Comparison

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Ray Medicine International Holding Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's Margin of Safety % (DCF FCF Based) falls into.


HKSE:06108
52GF Score
New Ray Medicine International Holding Ltd HKSE:06108
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is New Ray Medicine International Holding (HKSE:06108) Overvalued in 2026?

Based on GuruFocus' analysis, New Ray Medicine International Holding stock appears to be undervalued. The current stock price of HK$0.23 is trading 78.4% below its estimated GF Value™ of HK$1.04. GuruFocus considers New Ray Medicine International Holding to be Possible Value Trap.

Key valuation signals for HKSE:06108:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: HK$1.04 vs. price of HK$0.23 (78.4% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New Ray Medicine International Holding Business Description

Address 19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading and distribution of pharmaceutical products in the People's Republic of China. The company's segments include the Distribution and trading of pharmaceutical products and the Provision of marketing and promotion services. Distribution and trading of pharmaceutical products segment consist of Injection drugs and generate maximum revenue for the company.
52GF Score

Get the complete analysis for HKSE:06108

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.23
Price
HK$1.04
GF Value